Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/allos-pharma-inc-expands-intellectual-property-rights-for-arbaclofen-301930753.html
https://www.prnewswire.com/news-releases/allos-pharma-inc-receives-fda-guidance-for-the-design-of-a-phase-3-trial-to-support-a-new-drug-application-for-treatment-of-fragile-x-syndrome-301832340.html
https://www.prnewswire.com/news-releases/allos-pharma-inc-presents-new-positive-data-analyses-at-the-18th-nfxf-international-fragile-x-conference-301586445.html
http://www.fiercepharma.com/story/nih-urged-break-taboo-against-using-its-power-bypass-drug-patents/2016-01-14?utm_medium=rss&utm_source=rss&utm_campaign=rss